New medical advances could revolutionise the ability to treat undetected tuberculosis (TB) thanks to an international team of scientists led by the University of St Andrews.
the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.
Experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives.
The University of St Andrews in partnership with NIMR, TFDA and KCRI launched the SMERT (Streamlining health research ethics and medicines regulation) project on 23rd April 2018 in Dar es Salaam, the capital of Tanzania.
Dr. Wilber Sabiiti recently presented a paper at the Keystone Symposia on Translation of tuberculosis research into policy and practice.
Dr. Wilber Sabiiti spent several days with the Porton Down PHE tuberculosis (TB) research team training them and optimising their Real-time PCR platform QuantiStudio TM Vii 6 and 7 Flex to perform Molecular bacterial load assay (MBLA).
Dr Wilber Sabiiti and Dr Ewan Chrinside recently ran training sessions on translating research knowledge into commercial products and policies to practice at the recent TWENDE Course in Uganda.
Dr. Wilber Sabiiti recently presented some of his work at the UARC-TLD.
Hosted as part of the 6th East African Health and Scientific Research Conference and International trade fair the symposium was co-chaired by Dr. Wilber Sabiiti and Dr. Helen Meme of Kenya Medical Research Institute (KEMRI).
Dr Wilber Sabiiti has recently given a series of talks and training in different African countries showcasing the advantages of the molecular bacterial load assay (MBLA) and TWENDE work on developing model for rapid uptake of health research innovations into policy and practice.
- Page 1 of 2